Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,250 | 93,929 | 15,947 | 11,638 | 15,921 |
| Marketable Securities | 11,329 | 6,481 | N/A | N/A | N/A |
| TOTAL | $92,275 | $101,238 | $16,584 | $12,326 | $16,779 |
| Non-Current Assets | |||||
| PPE Net | 2,428 | 2,522 | 2,359 | 2,232 | 2,124 |
| Other Non-Current Assets | 1,113 | 1,081 | 1,138 | 1,078 | 989 |
| TOTAL | $3,541 | $3,603 | $3,496 | $3,310 | $3,113 |
| Total Assets | $95,816 | $104,840 | $20,081 | $15,635 | $19,892 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,414 | 9,971 | 10,709 | 9,939 | 9,240 |
| TOTAL | $10,540 | $10,111 | $10,851 | $10,010 | $9,307 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 912 | 934 | 965 | 972 | 991 |
| TOTAL | $912 | $934 | $965 | $972 | $991 |
| Total Liabilities | $11,452 | $11,044 | $11,816 | $10,982 | $10,299 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,411 | 52,965 | 33,578 | 28,834 | 27,877 |
| Common Shares | 5 | 5 | 3 | 3 | 3 |
| Retained earnings | -114,550 | -104,463 | -93,776 | -86,190 | -79,567 |
| Other shareholders' equity | 6 | -40 | -37 | -35 | -85 |
| TOTAL | $84,364 | $93,796 | $8,265 | $4,653 | $9,594 |
| Total Liabilities And Equity | $95,816 | $104,840 | $20,081 | $15,635 | $19,892 |